Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn's Disease.
Physicians and Scientists in Gastroenterology as Legislative Advocates: Practical Tips and Resources.
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.
Reactive Oxygen Species (ROS) in Metabolic Disease-Don't Shoot the Metabolic Messenger.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reactive Oxygen Species (ROS) in Metabolic Disease-Don't Shoot the Metabolic Messenger.
Reactive Oxygen Species (ROS) in Metabolic Disease-Don't Shoot the Metabolic Messenger. Int J Mol Sci. 2025 Mar 14; 26(6).
View in:
PubMed
subject areas
Animals
Homeostasis
Humans
Metabolic Diseases
Oxidative Stress
Reactive Oxygen Species
Signal Transduction
authors with profiles
Christopher J. Rhodes